Explaining Health Reform: Medicare and the New Independent Payment Advisory Board
This brief describes how the new board created under the 2010 health reform law is expected to limit the growth in Medicare spending over time.
View the Latest: Prescription Drugs
Filter
-
-
Medicare Part D 2010 Data Spotlight: The Coverage Gap
ReportThis data spotlight examines the coverage gap, or "doughnut hole," in Medicare stand-alone drug plans available in 2010. While in the gap in coverage, Part D enrollees (other than those receiving low-income subsidies) are required to pay 100 percent of total drug costs until they reach the catastrophic coverage level.
-
Federal Policies Affecting The Cost and Availability of New Pharmaceuticals
ReportThis report by Michael Gluck of the Georgetown University Institute for Health Care Research and Policy examines several ways in which the federal government influences the availability and cost of prescription drugs, including 1) intellectual property protection the laws and policies which regulate and influence patents and generic competition (include the Hatch-Waxman Act), 2) federal…
-
Florida’s Medicaid Prescription Drug Benefit: A Case Study
ReportFlorida's Medicaid Prescription Drug Benefit: A Case Study A new study summarizes and discusses the state s attempt to reform its Medicaid prescription drug benefit program.
-
Medicare and Prescription Drugs, Fact Sheet
Fact SheetThis fact sheet, updated in April 2003, profiles current sources of prescription drug coverage among the Medicare population, describes the characteristics of beneficiaries who lack drug coverage and the implications of being without such coverage, and provides current data on prescription drug use and spending. Fact Sheet (.
-
The Development of Direct-to-Consumer Prescription Drug Advertising Regulation
Other PostThis article, which appears in the Food and Drug Law Journal, vol. 57, no. 3, 2002, pp. 423-444 was based on a report written by F.B. Palumbo and C.D. Mullins at the University of Maryland School of Pharmacy Center on Drugs and Public Policy and funded by the Kaiser Family Foundation.
-
The Role of Health Coverage for People with Disabilities
Event Date:EventPeople with disabilities are at risk in the health-care system because of their wide-ranging health-care needs, their relatively heavy use of prescription drugs, health-care and support services, and typically low incomes. A new survey of people with permanent mental and/or physical disabilities explores their health-care experiences and challenges in accessing and paying for care.
-
Medicare Prescription Drugs and Low-Income Beneficiaries – Presentation
EventSummary of Low-Income Subsidy Program in Final Medicare Bill This presentation summarizes the dual eligible population, the low-income provisions of the new Medicare drug benefit and discusses the impact on state Medicaid programs. Presentation Slides (.
-
Retiree Health Benefits Now and in the Future, Report
ReportRetiree Health Benefits Now and In the Future - Report This survey, conducted by the Kaiser Family Foundation and Hewitt Associates between June and September 2003 provides detailed information on retiree health programs offered by large private-sector employers.
-
The “Clawback:” State Financing of Medicare Drug Coverage
Issue BriefThis issue paper describes the origins of the clawback, the formula by which each state’s clawback amount is calculated, and the clawback’s implications for states and for low-income Medicare beneficiaries. Issue Paper (.